Citations

Clear

1526 citation(s) found for "Sun, Bo".

Dimeric bis (heptyl)‐Cognitin Blocks Alzheimer's β‐Amyloid Neurotoxicity Via the Inhibition of Aβ Fibrils Formation and Disaggregation of Preformed Fibrils
Hu, Shengquan, Cui, Wei , Mak, Shinghung , Y, Hu , Lee, Ming‐Yuen, Pang, Yuan‐Ping , Han, Yifan , Wang, Rui Ting , Li, Gang , Lee, Ming‐Yuen, Han, Yifan , Pang, Yuan-Ping

Mayo Clinic

CNS Neuroscience & Therapeutics | October 28, 2015 | Volume: 21 | Issue: 12 | Pages: 953-961

10.1111/cns.12472 | PMID 26507365 Get It

SummaryAimsFibrillar aggregates of β‐amyloid protein (Aβ) are the main constituent of senile plaques and considered to be one of the causative events in the pathogenesis of Alzheimer's disease (AD). Compounds that could inhibit Aβ fibrils formation, disaggregate preformed Aβ fibrils as well as reduce their associated neurotoxicity might have therapeutic values for treating AD. In this study, the inhibitory effects of bis (heptyl)‐cognitin (B7C), a multifunctional dimer derived from tacrine, on aggregation and neurotoxicity of Aβ1‐40 were evaluated both in vitro and in vivo.MethodsThioflavin T fluorescence assay was carried out to evaluate Aβ aggregation, MTT and Hoechst‐staining assays were performed to investigate Aβ‐associated neurotoxicity. Fluorescent probe DCFH‐DA was used to estimate the accumulation of intracellular reactive oxygen stress (ROS). Morris water maze was applied to determine learning and memory deficits induced by intracerebroventricular infusion of Aβ in rats.ResultsB7C (0.1–10 μM), but not tacrine, effectively inhibited Aβ fibrils formation and disaggregated preformed Aβ fibrils following co‐incubation of B7C and Aβ monomers or preformed fibrils, respectively. In addition, B7C markedly reduced Aβ fibrils‐associated neurotoxicity in SH‐SY5Y cell line, as evidenced by the increase in cell survival, the decrease in Hoechst‐stained nuclei and in intracellular ROS. Most encouragingly, B7C (0.1 and 0.2 mg/kg), 10 times more potently than tacrine (1 and 2 mg/kg), inhibited memory impairments after intracerebroventricular infusion of Aβ in rats, as evidenced by the decrease in escape latency and the increase in the spatial bias in Morris water maze test along with upregulation of choline acetyltransferase activity and downregulation of acetylcholinesterase activity.ConclusionThese findings provide not only novel molecular insight into the potential application of B7C in treating AD, but also an effective approach for screening anti‐AD agents.
LncRNA MALAT1 enhances oncogenic activities of EZH2 in castration-resistant prostate cancer
Wang, Dejie , Ding, Liya , Wang, Liguo , Sun, Zhifu , Karnes, R. Jeffrey , Zhang, Jun , Zhao, Yu , Zhang, Jun, Huang, Haojie , Sun, Zhifu , Wang, Liguo

Mayo Clinic

Oncotarget | October 28, 2015 | Volume: 6 | Issue: 38 | Pages: 41045-41055

10.18632/oncotarget.5728 | PMID 26516927 Get It

A pig‐to‐mouse coronary artery transplantation model for investigating the pathogenicity of anti‐pig antibody
Miyagi, Naoto, Byrne, Guerard W. , Du, Zeji , Kogelberg, Heide, Gazi, Mozammel H., Tazelaar, Henry D. , Wang, Chunsheng , McGregor, Christopher G.A. , Lin, Yi, Tazelaar, Henry D.

Mayo Clinic

Xenotransplantation | October 23, 2015 | Volume: 22 | Issue: 6 | Pages: 458-467

10.1111/xen.12198 | PMID 26490445 Get It

AbstractBackgroundRejection of Gal‐free (GTKO) donor pig cardiac xenografts is strongly associated with vascular non‐Gal antibody binding, endothelial cell (EC) injury, and activation and microvascular thrombosis. We adopted a pig‐to‐SCID/beige small animal transplant model to compare the pathogenicity of baboon and human anti‐pig antibody.MethodsWild‐type (GT+) or GTKO porcine coronary arteries (PCAs) were transplanted into the infrarenal aorta of SCID/beige mice. Three days after transplant, recipients were infused with anti‐pig antibody (anti‐SLA class I, an isotype control, naive or sensitized baboon serum, or naive human serum). PCAs were recovered 24 h after antibody infusion and examined using histology, immunohistochemistry, and in situ hybridization.ResultsDose‐dependent intragraft thrombosis occurred after infusion of anti‐SLA I antibody (but not isotype control) in GT+ and GTKO PCA recipients. Naive baboon serum induced thrombosis in GT+ grafts. Thrombosis was significantly reduced by pre‐treating naive baboon serum with Gal polymer and not observed when this serum was infused to GTKO PCA recipients. Naive human serum caused dose‐dependent intragraft thrombosis of GTKO PCAs. In all cases, thrombosis involved graft‐specific vascular antibody and complement deposition, macrophage adherence, EC delamination, and subendothelial thrombus formation.ConclusionsThis study provides the first direct in vivo comparison of the pathogenicity of naive human and baboon serum. The results suggest that human preformed non‐Gal antibody may have increased pathogenicity compared to baboon. This model, which showed a rejected graft histopathology similar to antibody‐mediated rejection in cardiac xenotransplantation, may be useful to assess the pathogenicity of individual protein or carbohydrate specific non‐Gal reactive antibodies.
CpGFilter: model-based CpG probe filtering with replicates for epigenome-wide association studies
Chen, Jun , Just, Allan C. , Schwartz, Joel , Hou, Lifang , Jafari, Nadereh, Sun, Zhifu , Kocher, Jean‐Pierre , Baccarelli, Andrea , Lin, Xihong , Sun, Zhifu , Hou, Lifang

Mayo Clinic

Bioinformatics | October 9, 2015 | Volume: 32 | Issue: 3 | Pages: 469-471

10.1093/bioinformatics/btv577 | PMID 26449931 Get It

Abstract Summary: The development of the Infinium HumanMethylation450 BeadChip enables epigenome-wide association studies at a reduced cost. One observation of the 450K data is that many CpG sites the beadchip interrogates have very large measurement errors. Including these noisy CpGs will decrease the statistical power of detecting relevant associations due to multiple testing correction. We propose to use intra-class correlation coefficient (ICC), which characterizes the relative contribution of the biological variability to the total variability, to filter CpGs when technical replicates are available. We estimate the ICC based on a linear mixed effects model by pooling all the samples instead of using the technical replicates only. An ultra-fast algorithm has been developed to address the computational complexity and CpG filtering can be completed in minutes on a desktop computer for a 450K data set of over 1000 samples. Our method is very flexible and can accommodate any replicate design. Simulations and a real data application demonstrate that our whole-sample ICC method performs better than replicate-sample ICC or variance-based method. Availability and implementation: CpGFilter is implemented in R and publicly available under CRAN via the R package ‘CpGFilter’. Contact: chen.jun2@mayo.edu or xlin@hsph.harvard.edu Supplementary information: Supplementary data are available at Bioinformatics online.
Negative Regulation of the Vascular Smooth Muscle α-Actin Gene in Fibroblasts and Myoblasts: Disruption of Enhancer Function by Sequence-Specific Single-Stranded-DNA-Binding Proteins
Sun, Siquan, Stoflet, Elizabeth S., Cogan, John G., Strauch, Arthur R., Getz, Michael J.

Mayo Clinic

Molecular and Cellular Biology | October 9, 2015 | Volume: 15 | Issue: 5 | Pages: 2429-2436

10.1128/mcb.15.5.2429 | PMID 7739527 Get It

Transcriptome analysis indicates TFEB1 and YEATS4 as regulatory transcription factors for drug resistance of ovarian cancer
Kim, Yi Rang , Park, Mi Sung, Eum, Ki-Hwan, Kim, Juhee, Bae, Taejeong , Lee, Dae Ho , Choi, Jin Woo , Eum, Ki‐Hwan, Lee, Jeong Won , Bae, Taejeong

Mayo Clinic

Oncotarget | September 29, 2015 | Volume: 6 | Issue: 31 | Pages: 31030-31038

10.18632/oncotarget.5208 | PMID 26307679 Get It

A Hidden Role of the Inactivated FANCD2: Upregulating ΔNp63
Panneerselvam, Jayabal, Pickering, Anna, Tian, Hui , Zheng, Junnian , Fei, Peiwen, Zhang, Jun , Wang, Hong

Mayo Clinic

Oncotarget | September 16, 2015 | Volume: 4 | Issue: 9 | Pages: 1416-1426

10.18632/oncotarget.1217 | PMID 23965832 Get It

Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study
D’Souza, Anita , Dispenzieri, Angela , Wirk, Baldeep , Zhang, Mei-Jie , Kyle, Robert A. , Kumar, Shaji , Comenzo, Raymond L. , Cornell, Robert F. , Weiss, Brendan M. , Freytes, César O. , Scott, Emma C. , Landau, Heather , Moreb, Jan S. , Costa, Luciano J. , Ramanathan, Muthalagu , Kamble, Rammurti T., Olsson, Richard F. , Ganguly, Siddhartha , Kindwall‐Keller, Tamila L. , Hari, Parameswaran , Huang, Jiaxing, Peter Gale, Robert, Savani, Bipin N. , Vogl, Dan T. , Landau, Heather J., Callander, Natalie S. , Nishihori, Taiga , Kindwall-Keller, Tamila L, Mark, Tomer M, Zhang, Mei‐Jie , Huang, Jiaxing , Gertz, Morie A. , Gale, Robert Peter , Lazarus, Hillard M. , Wood, William A. , Mark, Tomer M , D'Souza, Anita , Dispenzieri, Angela , Olsson, Richard F , Costa, Luciano J , Hari, Parameswaran

Mayo Clinic

Journal of Clinical Oncology | September 14, 2015 | Volume: 33 | Issue: 32 | Pages: 3741-3749

10.1200/jco.2015.62.4015 | PMID 26371138 Get It

Purpose Autologous hematopoietic cell transplantation, or autotransplantation, is effective in light-chain amyloidosis (AL), but it is associated with a high risk of early mortality (EM). In a multicenter randomized comparison against oral chemotherapy, autotransplantation was associated with 24% EM. We analyzed trends in outcomes after autologous hematopoietic cell transplantation for AL in North America. Patients and Methods Between 1995 and 2012, 1,536 patients with AL who underwent autotransplantation at 134 centers were identified in the Center for International Blood and Marrow Transplant Research database. EM and overall survival (OS) were analyzed in three time cohorts: 1995 to 2000 (n = 140), 2001 to 2006 (n = 596), and 2007 to 2012 (n = 800). Hematologic and renal responses and factors associated with EM, relapse and/or progression, progression-free survival and OS were analyzed in more recent subgroups from 2001 to 2006 (n = 197) and from 2007 to 2012 (n = 157). Results Mortality at 30 and 100 days progressively declined over successive time periods from 11% and 20%, respectively, in 1995 to 2000 to 5% and 11%, respectively, in 2001 to 2006, and to 3% and 5%, respectively, in 2007 to 2012. Correspondingly, 5-year OS improved from 55% in 1995 to 2000 to 61% in 2001 to 2006 and to 77% in 2007 to 2012. Hematologic response to transplantation improved in the latest cohort. Renal response rate was 32%. Centers performing more than four AL transplantations per year had superior survival outcomes. In the multivariable analysis, cardiac AL was associated with high EM and inferior progression-free survival and OS. Autotransplantation in 2007 to 2012 and use of higher dosages of melphalan were associated with a lowered relapse risk. A Karnofsky score less than 80 and creatinine levels 2 mg/m2 or greater were associated with worsened OS. Conclusion Post-transplantation survival in AL has improved, with a dramatic reduction in early post-transplantation mortality and excellent 5-year survival. The risk-benefit ratio for autotransplantation has changed, and randomized comparison with nontransplantation approaches is again warranted.
Base Resolution Methylome Profiling: Considerations in Platform Selection, Data Preprocessing and Analysis
Sun, Zhifu , Cunningham, Julie M. , Kocher, Jean‐Pierre , Cunningham, Julie, Slager, Susan, Slager, Susan L. , Sun, Zhifu

Mayo Clinic

Epigenomics | September 14, 2015 | Volume: 7 | Issue: 5 | Pages: 813-828

10.2217/epi.15.21 | PMID 26366945 Get It